Sarinnapha M Vasunilashorn1,2, Tamara G Fong2,3,4, Asha Albuquerque4, Edward R Marcantonio1,2,5, Eva M Schmitt4, Douglas Tommet6, Yun Gou4, Thomas G Travison2,4,5, Richard N Jones6, Sharon K Inouye2,4,5. 1. Department of Medicine, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA, USA. 2. Harvard Medical School, Boston, MA, USA. 3. Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA. 4. Aging Brain Center, Institute for Aging Research, Hebrew SeniorLife, Boston, MA, USA. 5. Department of Medicine, Division of Gerontology, Beth Israel Deaconess Medical Center, Boston, MA, USA. 6. Departments of Psychiatry and Human Behavior and Neurology, Warren Alpert Medical School, Brown University, Boston, MA, USA.
Abstract
BACKGROUND: Delirium has been associated with more rapid cognitive decline. However, it is unknown whether increased delirium severity is associated with a higher rate of long-term cognitive decline. OBJECTIVE: To evaluate delirium severity and the presence and rate of cognitive decline over 36 months following surgery. METHODS: We examined patients from the Successful Aging after Elective Surgery Study, who were age ≥70 years undergoing major elective surgery (N = 560). Delirium severity was determined by the peak Confusion Assessment Method-Severity (CAM-S) score for each patient's hospitalization and grouped based on the sample distribution: scores of 0-2, 3-7, and 8-19. A neuropsychological composite, General Cognitive Performance (GCP), and proxy-reported Informant Questionnaire for Cognitive Decline (IQCODE) were used to examine cognitive outcomes following surgery at 0, 1, and 2 months, and then every 6 months for up to 3 years. RESULTS: No significant cognitive decline was observed for patients with peak CAM-S scores 0-2 (-0.17 GCP units/year, 95% confidence interval [CI] -0.35, 0.01). GCP scores decreased significantly in the group with peak CAM-S scores 3-7 (-0.30 GCP units/year, 95% CI -0.51, -0.09), and decreased almost three times faster in the highest delirium severity group (peak CAM-S scores 8-19; -0.82 GCP units/year, 95% CI -1.28, -0.37). A similar association was found for delirium severity and the proportion of patients who developed IQCODE impairment over time. CONCLUSION: Patients with the highest delirium severity experienced the greatest rate of cognitive decline, which exceeds the rate previously observed for patients with dementia, on serial neuropsychological testing administered over 3 years, with a dose-response relationship between delirium severity and long-term cognitive decline.
BACKGROUND:Delirium has been associated with more rapid cognitive decline. However, it is unknown whether increased delirium severity is associated with a higher rate of long-term cognitive decline. OBJECTIVE: To evaluate delirium severity and the presence and rate of cognitive decline over 36 months following surgery. METHODS: We examined patients from the Successful Aging after Elective Surgery Study, who were age ≥70 years undergoing major elective surgery (N = 560). Delirium severity was determined by the peak Confusion Assessment Method-Severity (CAM-S) score for each patient's hospitalization and grouped based on the sample distribution: scores of 0-2, 3-7, and 8-19. A neuropsychological composite, General Cognitive Performance (GCP), and proxy-reported Informant Questionnaire for Cognitive Decline (IQCODE) were used to examine cognitive outcomes following surgery at 0, 1, and 2 months, and then every 6 months for up to 3 years. RESULTS: No significant cognitive decline was observed for patients with peak CAM-S scores 0-2 (-0.17 GCP units/year, 95% confidence interval [CI] -0.35, 0.01). GCP scores decreased significantly in the group with peak CAM-S scores 3-7 (-0.30 GCP units/year, 95% CI -0.51, -0.09), and decreased almost three times faster in the highest delirium severity group (peak CAM-S scores 8-19; -0.82 GCP units/year, 95% CI -1.28, -0.37). A similar association was found for delirium severity and the proportion of patients who developed IQCODE impairment over time. CONCLUSION:Patients with the highest delirium severity experienced the greatest rate of cognitive decline, which exceeds the rate previously observed for patients with dementia, on serial neuropsychological testing administered over 3 years, with a dose-response relationship between delirium severity and long-term cognitive decline.
Authors: Jane S Saczynski; Edward R Marcantonio; Lien Quach; Tamara G Fong; Alden Gross; Sharon K Inouye; Richard N Jones Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Jane S Saczynski; Cyrus M Kosar; Guoquan Xu; Margaret R Puelle; Eva Schmitt; Richard N Jones; Edward R Marcantonio; Bonnie Wong; Ilean Isaza; Sharon K Inouye Journal: J Am Geriatr Soc Date: 2014-02-10 Impact factor: 5.562
Authors: Giuseppe Bellelli; Paolo Mazzola; Alessandro Morandi; Adriana Bruni; Lucio Carnevali; Maurizio Corsi; Giovanni Zatti; Antonella Zambon; Giovanni Corrao; Birgitta Olofsson; Yngve Gustafson; Giorgio Annoni Journal: J Am Geriatr Soc Date: 2014-06-02 Impact factor: 5.562
Authors: Eva M Schmitt; Jane S Saczynski; Cyrus M Kosar; Edward R Marcantonio; Thomas Travison; Sharon K Inouye; Richard N Jones; David C Alsop; Tamara G Fong; Eran Metzger; Zara Cooper Journal: J Am Geriatr Soc Date: 2015-12-14 Impact factor: 5.562
Authors: Margaret A Pisani; So Yeon Joyce Kong; Stanislav V Kasl; Terrence E Murphy; Katy L B Araujo; Peter H Van Ness Journal: Am J Respir Crit Care Med Date: 2009-09-10 Impact factor: 21.405
Authors: Sarinnapha M Vasunilashorn; Long H Ngo; Sharon K Inouye; Tamara G Fong; Richard N Jones; Simon T Dillon; Towia A Libermann; Margaret O'Connor; Steven E Arnold; Zhongcong Xie; Edward R Marcantonio Journal: Alzheimers Dement Date: 2020-01-04 Impact factor: 21.566
Authors: Richard N Jones; Sevdenur Cizginer; Laura Pavlech; Asha Albuquerque; Lori A Daiello; Kumar Dharmarajan; Lauren J Gleason; Benjamin Helfand; Lauren Massimo; Esther Oh; Olivia I Okereke; Patricia Tabloski; Laura A Rabin; Jirong Yue; Edward R Marcantonio; Tamara G Fong; Tammy T Hshieh; Eran D Metzger; Kristen Erickson; Eva M Schmitt; Sharon K Inouye Journal: JAMA Intern Med Date: 2019-02-01 Impact factor: 21.873
Authors: Heidi Lindroth; Lisa Bratzke; Sara Twadell; Paul Rowley; Janie Kildow; Mara Danner; Lily Turner; Brandon Hernandez; Roger Brown; Robert D Sanders Journal: Int J Geriatr Psychiatry Date: 2019-04-23 Impact factor: 3.485
Authors: Elizabeth Mahanna-Gabrielli; Katie J Schenning; Lars I Eriksson; Jeffrey N Browndyke; Clinton B Wright; Deborah J Culley; Lis Evered; David A Scott; Nae Yah Wang; Charles H Brown; Esther Oh; Patrick Purdon; Sharon Inouye; Miles Berger; Robert A Whittington; Catherine C Price; Stacie Deiner Journal: Br J Anaesth Date: 2019-08-19 Impact factor: 9.166
Authors: Christopher R Carpenter; Frances McFarland; Michael Avidan; Miles Berger; Sharon K Inouye; Jason Karlawish; Frank R Lin; Edward Marcantonio; John C Morris; David B Reuben; Raj C Shah; Heather E Whitson; Sanjay Asthana; Joe Verghese Journal: J Am Geriatr Soc Date: 2019-08-22 Impact factor: 5.562
Authors: Annie M Racine; Madeline D'Aquila; Eva M Schmitt; Jacqueline Gallagher; Edward R Marcantonio; Richard N Jones; Sharon K Inouye; Dena Schulman-Green Journal: Gerontologist Date: 2019-09-17